{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:04Z","timestamp":1792787884452,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Science Innovation Fund for Medical Science","award":["2021-CXGC08"],"award-info":[{"award-number":["2021-CXGC08"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-GSP-GG-9"],"award-info":[{"award-number":["2022-GSP-GG-9"]}]},{"name":"Beijing Natural Science Foundation","award":["7222143"],"award-info":[{"award-number":["7222143"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05944-0","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:14:06Z","timestamp":1782746046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined impact of microalbuminuria and obesity on cardiovascular outcomes in hospitalized heart failure patients: a cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Guo","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"3","key":"5944_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jacc.2022.10.028","volume":"81","author":"MS Khan","year":"2023","unstructured":"Khan MS, Shahid I, Anker SD, Fonarow GC, Fudim M, Hall ME, et al. Albuminuria and heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(3):270\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2022.10.028. PubMed PMID: 36653095.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5944_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/01.cir.102.2.203","volume":"102","author":"HL Hillege","year":"2000","unstructured":"Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102(2):203\u201310. https:\/\/doi.org\/10.1161\/01.cir.102.2.203. PubMed PMID: 10889132.","journal-title":"Circulation"},{"issue":"1","key":"5944_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","volume":"47","author":"RW Schrier","year":"2006","unstructured":"Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006;47(1):1\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2005.07.067. PubMed PMID: 16386657.","journal-title":"J Am Coll Cardiol"},{"issue":"4S","key":"5944_CR4","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"1","key":"5944_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cardfail.2015.10.009","volume":"22","author":"A Odutayo","year":"2016","unstructured":"Odutayo A, Hsiao AJ, Emdin CA. Prevalence of albuminuria in a general population cohort of patients with established chronic heart failure. J Card Fail. 2016;22(1):33\u20137. https:\/\/doi.org\/10.1016\/j.cardfail.2015.10.009. PubMed PMID: 26505813.","journal-title":"J Card Fail"},{"issue":"1","key":"5944_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.ajkd.2011.02.391","volume":"58","author":"S Blecker","year":"2011","unstructured":"Blecker S, Matsushita K, K\u00f6ttgen A, Loehr LR, Bertoni AG, Boulware LE, et al. High-normal albuminuria and risk of heart failure in the community. Am J Kidney Dis. 2011;58(1):47\u201355. https:\/\/doi.org\/10.1053\/j.ajkd.2011.02.391. PubMed PMID: 21549463; PubMed Central PMCID: PMC3119712.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5944_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jchf.2019.01.016","volume":"7","author":"LN Bailey","year":"2019","unstructured":"Bailey LN, Levitan EB, Judd SE, Sterling MR, Goyal P, Cushman M, et al. Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults. JACC Heart Fail. 2019;7(5):394\u2013401. https:\/\/doi.org\/10.1016\/j.jchf.2019.01.016. PubMedPMID: 31047019; PubMedCentralPMCID: PMC6544368.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"5944_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M23-2814","volume":"177","author":"A Verma","year":"2024","unstructured":"Verma A, Schmidt IM, Claudel S, Palsson R, Waikar SS, Srivastava A. Association of albuminuria with chronic kidney disease progression in persons with chronic kidney disease and normoalbuminuria\u202f: a cohort study. Ann Intern Med. 2024;177(4):467\u201375. https:\/\/doi.org\/10.7326\/M23-2814. PubMed PMID: 38560911; PubMed Central PMCID: PMC12124184.","journal-title":"Ann Intern Med"},{"key":"5944_CR9","unstructured":"National Clinical Guideline Centre (UK). Chronic Kidney Disease (Partial Update): Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care. London: National Institute for Health and Care Excellence (UK); 2014. (National Institute for Health and Care Excellence: Clinical Guidelines). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK248058\/ . PubMed PMID: 25340245.\u00a0Cited 2025 Jun 2."},{"issue":"10258","key":"5944_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223\u201349. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2.","journal-title":"Lancet"},{"issue":"7","key":"5944_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.115.016801","volume":"133","author":"D Aune","year":"2016","unstructured":"Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133(7):639\u201349. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016801. PubMed PMID: 26746176.","journal-title":"Circulation"},{"issue":"9","key":"5944_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jacc.2016.11.081","volume":"69","author":"A Pandey","year":"2017","unstructured":"Pandey A, LaMonte M, Klein L, Ayers C, Psaty BM, Eaton CB, et al. Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol. 2017;69(9):1129\u201342. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.081. PubMed PMID: 28254175; PubMed Central PMCID: PMC5848099.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"5944_CR13","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/ejhf.2308","volume":"23","author":"C Adamson","year":"2021","unstructured":"Adamson C, Jhund PS, Docherty KF, B\u011blohl\u00e1vek J, Chiang CE, Diez M, et al. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. Eur J Heart Fail. 2021;23(10):1662\u201372. https:\/\/doi.org\/10.1002\/ejhf.2308. PubMed PMID: 34272791; PubMed Central PMCID: PMC9292627.","journal-title":"Eur J Heart Fail"},{"issue":"41","key":"5944_CR14","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1093\/eurheartj\/ehac481","volume":"43","author":"C Adamson","year":"2022","unstructured":"Adamson C, Kondo T, Jhund PS, de Boer RA, Cabrera Honorio JW, Claggett B, et al. Dapagliflozin for heart failure according to body mass index: the DELIVER trial. Eur Heart J. 2022;43(41):4406\u201317. https:\/\/doi.org\/10.1093\/eurheartj\/ehac481. PubMed PMID: 36029309; PubMed Central PMCID: PMC9622300.","journal-title":"Eur Heart J"},{"issue":"1","key":"5944_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/heartjnl-2019-314770","volume":"106","author":"R Mahajan","year":"2020","unstructured":"Mahajan R, Stokes M, Elliott A, Munawar DA, Khokhar KB, Thiyagarajah A, et al. Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis. Heart. 2020;106(1):58\u201368. https:\/\/doi.org\/10.1136\/heartjnl-2019-314770. PubMed PMID: 31530572.","journal-title":"Heart"},{"key":"5944_CR16","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.931808","volume":"27","author":"Y Liu","year":"2021","unstructured":"Liu Y, Song M, Huang L, Zhu G. \u201cObesity paradox\u201d in acute respiratory distress syndrome among patients undergoing cardiac surgery: a retrospective study. Med Sci Monit. 2021;27:e931808. https:\/\/doi.org\/10.12659\/MSM.931808. PubMed PMID: 34429393; PubMed Central PMCID: PMC8404469.","journal-title":"Med Sci Monit"},{"issue":"12","key":"5944_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.120.045888","volume":"142","author":"MS Khan","year":"2020","unstructured":"Khan MS, Fonarow GC, McGuire DK, Hernandez AF, Vaduganathan M, Rosenstock J, et al. Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization. Circulation. 2020;142(12):1205\u201318. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045888. PubMed PMID: 32955939.","journal-title":"Circulation"},{"issue":"1","key":"5944_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-290","volume":"12","author":"JM Zacharias","year":"2012","unstructured":"Zacharias JM, Young TK, Riediger ND, Roulette J, Bruce SG. Prevalence, risk factors and awareness of albuminuria on a Canadian First Nation: a community-based screening study. BMC Public Health. 2012;12(1):290. https:\/\/doi.org\/10.1186\/1471-2458-12-290.","journal-title":"BMC Public Health"},{"issue":"11","key":"5944_CR19","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1038\/s41366-020-0642-3","volume":"44","author":"P Zhu","year":"2020","unstructured":"Zhu P, Lewington S, Haynes R, Emberson J, Landray MJ, Cherney D, et al. Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank. Int J Obes (Lond). 2020;44(11):2256\u201366. https:\/\/doi.org\/10.1038\/s41366-020-0642-3.","journal-title":"Int J Obes (Lond)"},{"key":"5944_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.941926","volume":"9","author":"Z Qin","year":"2022","unstructured":"Qin Z, Chang K, Yang Q, Yu Q, Liao R, Su B. The association between weight-adjusted-waist index and increased urinary albumin excretion in adults: a population-based study. Front Nutr. 2022;9:941926. https:\/\/doi.org\/10.3389\/fnut.2022.941926. PubMed PMID: 36034904; PubMed Central PMCID: PMC9412203.","journal-title":"Front Nutr"},{"issue":"4","key":"5944_CR21","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","volume":"59","author":"N Kambham","year":"2001","unstructured":"Kambham N, Markowitz GS, Valeri AM, Lin J, D\u2019Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498\u2013509. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.0590041498.x. PubMed PMID: 11260414.","journal-title":"Kidney Int"},{"issue":"7","key":"5944_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/HJH.0000000000003434","volume":"41","author":"D Moriconi","year":"2023","unstructured":"Moriconi D, Mengozzi A, Duranti E, Cappelli F, Taddei S, Nannipieri M, et al. The renal resistive index is associated with microvascular remodeling in patients with severe obesity. J Hypertens. 2023;41(7):1092\u20139. https:\/\/doi.org\/10.1097\/HJH.0000000000003434. PubMed PMID: 37071436; PubMed Central PMCID: PMC10242520.","journal-title":"J Hypertens"},{"issue":"4","key":"5944_CR23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11255-012-0300-3","volume":"45","author":"F Han","year":"2013","unstructured":"Han F, Hou N, Miao W, Sun X. Correlation of ultrasonographic measurement of intrarenal arterial resistance index with microalbuminuria in nonhypertensive, nondiabetic obese patients. Int Urol Nephrol. 2013;45(4):1039\u201345. https:\/\/doi.org\/10.1007\/s11255-012-0300-3. PubMed PMID: 23054319.","journal-title":"Int Urol Nephrol"},{"key":"5944_CR24","doi-asserted-by":"publisher","unstructured":"Authors\/Task Force Members:, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333 PubMed PMID: 35083827.","DOI":"10.1002\/ejhf.2333"},{"issue":"35","key":"5944_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2025.105594","volume":"30","author":"MG Bellicini","year":"2025","unstructured":"Bellicini MG. HFpEF diagnosis: a controversial construct in modern cardiology. JACC Case Rep. 2025;30(35):105594. https:\/\/doi.org\/10.1016\/j.jaccas.2025.105594. PubMed PMID: 41065604; PubMed Central PMCID: PMC12790248.","journal-title":"JACC Case Rep"},{"issue":"18","key":"5944_CR26","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"BA Borlaug","year":"2022","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2022;118(18):3434\u201350. https:\/\/doi.org\/10.1093\/cvr\/cvac120.","journal-title":"Cardiovasc Res"},{"key":"5944_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.hjc.2024.06.008","volume":"87","author":"M Candemir","year":"2026","unstructured":"Candemir M, K\u0131z\u0131ltun\u00e7 E, Nurko\u00e7 SG, Cihan B, \u015eahinarslan A. Predictors of length of hospital stay and in-hospital adverse events in patients with acute decompensated heart failure: in-hospital 24-hour blood pressure monitoring data. Hellenic J Cardiol. 2026;87:42\u201351. https:\/\/doi.org\/10.1016\/j.hjc.2024.06.008. PubMed PMID: 38925251.","journal-title":"Hellenic J Cardiol"},{"issue":"4","key":"5944_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/eurjhf\/hfs001","volume":"14","author":"M Miura","year":"2012","unstructured":"Miura M, Shiba N, Nochioka K, Takada T, Takahashi J, Kohno H, et al. Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study. Eur J Heart Fail. 2012;14(4):367\u201376. https:\/\/doi.org\/10.1093\/eurjhf\/hfs001. PubMed PMID: 22298637.","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"5944_CR29","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184. PubMed PMID: 37807924.","journal-title":"Circulation"},{"issue":"1","key":"5944_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","volume":"144","author":"C Hsu","year":"2006","unstructured":"Hsu C, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21\u20138. https:\/\/doi.org\/10.7326\/0003-4819-144-1-200601030-00006.","journal-title":"Ann Intern Med"},{"key":"5944_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5301","volume":"364","author":"AR Chang","year":"2019","unstructured":"Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364:k5301. https:\/\/doi.org\/10.1136\/bmj.k5301. PubMed PMID: 30630856; PubMed Central PMCID: PMC6481269.","journal-title":"BMJ"},{"issue":"2","key":"5944_CR32","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1210\/clinem\/dgab633","volume":"107","author":"C Ye","year":"2022","unstructured":"Ye C, Kong L, Zhao Z, Li M, Wang S, Lin H, et al. Causal associations of obesity with chronic kidney disease and arterial stiffness: a Mendelian randomization study. J Clin Endocrinol Metab. 2022;107(2):e825\u201335. https:\/\/doi.org\/10.1210\/clinem\/dgab633. PubMed PMID: 34448477.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5944_CR33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cmet.2023.03.014","volume":"35","author":"SY Zhang","year":"2023","unstructured":"Zhang SY, Bruce K, Danaei Z, Li RJW, Barros DR, Kuah R, et al. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight. Cell Metab. 2023;35(5):875-886.e5. https:\/\/doi.org\/10.1016\/j.cmet.2023.03.014. PubMed PMID: 37060902.","journal-title":"Cell Metab"},{"issue":"4","key":"5944_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.kint.2022.06.010","volume":"102","author":"K Shahzad","year":"2022","unstructured":"Shahzad K, Fatima S, Khawaja H, Elwakiel A, Gadi I, Ambreen S, et al. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease. Kidney Int. 2022;102(4):766\u201379. https:\/\/doi.org\/10.1016\/j.kint.2022.06.010. PubMed PMID: 35779608.","journal-title":"Kidney Int"},{"issue":"6","key":"5944_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991\u20131006. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305697.","journal-title":"Circ Res"},{"issue":"2","key":"5944_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.ajkd.2010.06.005","volume":"56","author":"AS Levey","year":"2010","unstructured":"Levey AS, Kramer H. Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis. 2010;56(2):255\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2010.06.005. PubMed PMID: 20659626.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5944_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad252","volume":"53","author":"T Lin","year":"2024","unstructured":"Lin T, Jiang T, Huang X, Xu P, Liang R, Song Q, et al. Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis. Age Ageing. 2024;53(1):afad252. https:\/\/doi.org\/10.1093\/ageing\/afad252.","journal-title":"Age Ageing"},{"issue":"4","key":"5944_CR38","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1053\/j.ajkd.2014.11.015","volume":"65","author":"LJ Maple-Brown","year":"2015","unstructured":"Maple-Brown LJ, Hughes JT, Chatfield MD, Ward LC, Piers LS, Jones GRD, et al. Adding measures of body composition to the CKD-EPI GFR estimating equation in Indigenous Australians: the eGFR study. Am J Kidney Dis. 2015;65(4):632\u20134. https:\/\/doi.org\/10.1053\/j.ajkd.2014.11.015. PubMed PMID: 25618185.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"5944_CR39","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.120.045888","volume":"142","author":"MS Khan","year":"2020","unstructured":"Khan MS, Fonarow GC, McGuire DK, Hernandez AF, Vaduganathan M, Rosenstock J, et al. Glucagon-like peptide 1 receptor agonists and heart failure: The need for further evidence generation and practice guidelines optimization. Circulation. 2020;142(12):1205\u201318. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045888. PubMed PMID: 32955939.","journal-title":"Circulation"},{"issue":"10","key":"5944_CR40","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/ejhf.2308","volume":"23","author":"C Adamson","year":"2021","unstructured":"Adamson C, Jhund PS, Docherty KF, B\u011blohl\u00e1vek J, Chiang CE, Diez M, et al. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. Eur J Heart Fail. 2021;23(10):1662\u201372. https:\/\/doi.org\/10.1002\/ejhf.2308. PubMed PMID: 34272791; PubMed Central PMCID: PMC9292627.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"5944_CR41","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ijo.2013.203","volume":"38","author":"R Padwal","year":"2014","unstructured":"Padwal R, McAlister FA, McMurray JJV, Cowie MR, Rich M, Pocock S, et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond). 2014;38(8):1110\u20134. https:\/\/doi.org\/10.1038\/ijo.2013.203.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"5944_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","volume":"136","author":"M Obokata","year":"2017","unstructured":"Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136(1):6\u201319. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026807. PubMed PMID: 28381470; PubMed Central PMCID: PMC5501170.","journal-title":"Circulation"},{"issue":"10437","key":"5944_CR43","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","volume":"403","author":"J Butler","year":"2024","unstructured":"Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstr\u00f8m SZ, Davies MJ, et al. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet. 2024;403(10437):1635\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(24)00469-0. PubMed PMID: 38599221; PubMed Central PMCID: PMC11317105.","journal-title":"Lancet"},{"issue":"2","key":"5944_CR44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1681\/ASN.2017070819","volume":"29","author":"KL Nowak","year":"2018","unstructured":"Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, et al. Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2018;29(2):571\u20138. https:\/\/doi.org\/10.1681\/ASN.2017070819. PubMed PMID: 29118087; PubMed Central PMCID: PMC5791072.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5944_CR45","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/s0272-6386(01)80120-7","volume":"37","author":"F Bonnet","year":"2001","unstructured":"Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthez\u00e8ne F, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis. 2001;37(4):720\u20137. https:\/\/doi.org\/10.1016\/s0272-6386(01)80120-7. PubMed PMID: 11273871.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"5944_CR46","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/joim.13355","volume":"290","author":"LM Pammer","year":"2021","unstructured":"Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, et al. Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort. J Intern Med. 2021;290(6):1219\u201332. https:\/\/doi.org\/10.1111\/joim.13355. PubMed PMID: 34342064.","journal-title":"J Intern Med"},{"issue":"22","key":"5944_CR47","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.jacc.2017.09.1111","volume":"70","author":"T Tsujimoto","year":"2017","unstructured":"Tsujimoto T, Kajio H. Abdominal obesity is associated with\u00a0an\u00a0increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol. 2017;70(22):2739\u201349. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.1111.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5944_CR48","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jchf.2014.05.016","volume":"2","author":"DH Katz","year":"2014","unstructured":"Katz DH, Burns JA, Aguilar FG, Beussink L, Shah SJ. Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail. 2014;2(6):586\u201396. https:\/\/doi.org\/10.1016\/j.jchf.2014.05.016.","journal-title":"JACC Heart Fail"},{"issue":"19","key":"5944_CR49","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","volume":"34","author":"FP Brouwers","year":"2013","unstructured":"Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/eht066.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05944-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:15:36Z","timestamp":1790036136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05944-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5944"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05944-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with the principles outlined in the Declaration of Helsinki and was approved by the ethics committee of Fuwai hospital (Approval number:2024-ZX035). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"823"}}